Blood circulation

↓Triglycerides 30%

↑Vasodilation 5-15%

Hcy↓ +31%

FMD/AIx↑

Vasodilation + blood flow

−39% AF recurrence

Phosphorus↓, calcification↓

Blood flow↑, resistance↓

BP↓ nitrite↑

Flow↑ pressure↓

Tolerance-related flow changes

Vasodilation ↑, FMD +

BP / Viscosity ↓

Lower clotting, events

Lower lipids, BP

↓AA-platelets

↑EPA/AA,↓TxB2

NO vasodilation +blood flow

BP↓; flow↑

+135% arginine, flow↑

Improved dilation, flow

+31%, -26%

Lower constriction, clotting

↑GSH,↓MDA,better flow

↓viscosity,↑deformability

Platelets/vasoconstriction ↓

BP/stiffness ↓

Circulation/function ↑

HDL↑ LDL↓

CIMT/FMD +22%

Blood flow↑

Exercise +1.5 min

Blood flow/flow reserve

MACE -2.4%

Perfusion ↑; mRS +15%

Platelet flow ↓; TXB2 -35%

Improved blood flow +37%

Lower stiffness, BP, lipids

Circulation, ischemia +

Endothelial function, BP

Blood flow, viscosity

↑ flow, walking

↓ BP, inflammation

BP ↓5 mmHg

Lipids/vascular function

TG↓ LDL↓

Vessel dilation, BP ↓

Lipids/platelets, circulation ↑

Walking/ABI ↑

BP/artery flow ↑

Venous tone/hemodynamics

Edema/symptoms -1.3%

Microcirculation/ulcers/healing

Leg swelling/symptoms

Microcirculation/flow improved

Cardiac output +12%

Calcification/stiffness ↓

Mortality HR↓

Endothelial function +FMD

Lower BP/ADMA

Microcirculation, flow

+ no-reflow

Cardiac function, ATP

↓ thrombosis 86.7%

↓ BP 11.7%

↑ flow/endothelium

Vasodilation +FMD

BP lowers -18 mmHg

Cardiac events ↓50%

Flow/oxygenation +

Walking/healing +

Cholesterol ↓ 10%

BP / endothelial ↑

Triglycerides / clotting ↓

Better vasodilation +63%

Lower BP -12 mmHg

More lycopene, less inflammation

Vasodilation/FMD +34%

Cerebral blood flow +35%

Platelet↓ clotting

Blood flow↑ BP↓

BP -18/16 mmHg

LDL -6-9%

FMD +1-5 pp

↑ circulation flow

↓ blood pressure

↑ NO blood flow

↓ BP / stiffness

Vasodilation +41% FBF

Blood pressure -7.5 mmHg

Edema/leakage reduced

BP↓, lipids↓

Hemorrhage↓, circulation↑

BP↓, blood flow↑

vein tone↓, +2.5mmHg

endothelial function↑, inflammation↓

Better vessel function

Lower LDL/oxidation

Antiplatelet, -70%

Walking, lipids

BP ↓ ~15-17 mmHg

Diuresis/natriuresis ↑

Vascular function ↑

Lower BP, better flow

−5 to −7 mmHg

Blood pressure ↓

Blood flow ↑

BP↓, +22% EF

Lactate↓, microcirculation↑

Improved perfusion, lactate ↓

Better cardiac output, urine ↑

Plaque stabilization +8.8 GSM

Microcirculation/edema improved

Bleeding/thrombosis reduced

↑/↓ BP, +4.5

↑ circulation, better exercise

Better vessel dilation

Lower blood pressure

Reduced clotting

Lipids ↓; FMD +3%

Blood pressure/stiffness ↓

LDL/TC ↓

Skin blood flow ↑

Blood pressure ↓

Systolic −7.3 mmHg

Endothelial function, IMT

Blood pressure, fibrinolysis

Vaginal flow, PI -56%

↓ arterial stiffness

↓ MI 16.9%

Better pump function

−LVEF, +flow

Less inflammation

RBF +52.8%

Circulation enzyme boost

Vessel flow/bleeding

EPA/DHA rises +1.04

Triglycerides down ~10%

ApoC3/non-HDL down

Leg edema ↓ 44 mL

Venous flow measures improved

Hearing ↑ >10 dB

Platelet/clotting ↓

BP/endothelial changes ↓

Lipid/blood flow: LDL -13.6%

Ventricular normalization: 74.29%

Anticoagulation up; clotting times

+SBP/DBP down; D-dimer up

Vasodilation/FMD +28%

Blood pressure -7 mmHg

HDL↑ LDL↓

Lower BP, ↑ flow

Better O2 use, endurance

Peripheral flow ↑

BP/HDL/Hb? changed

Clot breakdown ↑

Vasodilation + BP↓

EF +8%

LDL, oxidative damage -17.21

Arrhythmia markers +39.7%

Edema, albumin/endothelin down

Pumping +LVEF

Vasodilation +80%

↑FMD, BP↓

↑CO, ↓TPR

Venous tone, -1.25 mm

Swelling, symptoms improve

Leg volume -20.5 ml

FMD +1.6%

+eNOS, -SBP

LDL/NO ↑, vessels better

Inflammation/oxidative damage ↓

Lipid-lowering: LDL -19.9

Glucose control: HbA1c -0.68%

HDL up: +2.83

Skin flow ↑ capsaicin

CGRP block lowers flow

Heat vasodilation ↓

Endothelial function +FMD

Lower injury/oxidation markers

Better circulation +LVEF

BP ↓ 3-6 mmHg

Stiffness/IL-8 ↓

TTR +20%

Adherence, knowledge improved

Memory + BP (−7 mmHg)

Executive/memory + BP

BP normalizes; lipids drop

Exercise rise blunted

Lower viscosity, better flow

↓8.2 mmHg BP, ↓LDL

Lower weight, better HDL

Less insulin resistance

Vein visibility +50%

IV attempts -50%

Better arterial compliance

+23% compliance

Lower BP / resistance

Vessel function, BP

Oxygenation, circulation

FMD ↑ ~+1.1%

PWV/cfPWV ↓

Better vessel function

HDL +7.7–11.4%

Lower stiffness

DBP ↓ at 2h

SBP ↓ ~12.5 mmHg

Triglycerides ↑ 22.1%

Choroidal flow +

Endothelial/metabolic +

Vein dilation +3.6 mm

Phlebitis reduced

Stroke outcome mRS

ADL unchanged

BP -10/6 mmHg

IMT/events lower

Glucose/stiffness lower

BP, TG, CRP −9.7

LDL, glucose, HbA1c −21.9%

↑ nitrite/nitrate

↓ LDL -13%

↓ sdLDL; ↑ sterols

Lower BP, -1.51 cm

Better circulation, reduced BP

Improved blood flow +1.36

Lower BP -7.7/-5.5

BP -; glucose -

Inflammation/proteinuria -

Lipids and BP down

Triglycerides/cholesterol↓, BP↓

Platelet aggregation −8%

Blood flow unchanged

↑ vascular resistance

+BP ↓

↓ TG ↑ HDL

BP ↓

antioxidants ↑ memory ↑

↓FBS/IR; better vessels

dose-dependent, no %

DBP -4.8 mmHg

Cholesterol decrease

↑ vaginal blood flow: PI -3.85

↑ tissue health: VMI +35

FMD +

Endothelial function +

↓ carotid plaque/IMT

↓ hs-CRP

Lipids/glucose LDL, FBS

Inflammation/kidney TG −23.66%

Lower BP -3.4/-5.0

Improved glucose -0.36%

Heart rate −4%

IL-6 rise blunted

HDL up, risk down

+0.08 mmol/L HDL

BP improved

Stress tolerance up

Blood pressure -7 mmHg

Cholesterol/glucose lower

Improved erections +82.4%

No blood test change

HDL up; LDL down

DUB, HIR; LDL -

20-HETE -30%, no BP

Blood pressure unchanged